Stephens & Co. analyst Terry McEvoy maintains Stock Yards Bancorp (NASDAQ:SYBT) with a Equal-Weight and raises the price target from $74 to $76.
Oncternal Therapeutics Reports Patient Death In Mid-Stage Blood Cancer Study Treated With Second Dose Level
Oncternal Therapeutics Inc (NASDAQ: ONCT) updated the status of a recent study involving a treatment for relapsed or refractory aggressive B-cell lymphoma, including patients who have failed